After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
R Ashwin called Rishabh Pant 'Inzamam of Pakistan' and gave great advice to crush England.
Senior off-spinner Ravichandran Ashwin gave a detailed analysis of the Indian team's five-wicket
Srinagar: One Lashkar-e-Taiba terrorist arrested during a search operation in Chadoora
Irrespective of the snowfall and rain in Kashmir, the security forces are continuing their operat
Three schools in Delhi have received bomb threats. This threat has been sent to the schools by ma
The central government on Monday refuted media reports that claimed that the GST (Goods and Servi
People got great relief from the rain with a strong thunderstorm in Delhi last Sunday. The mercur
North Korea is going through a food crisis. A large population here is on the verge of starvation
The future of 7,000 Indian students pursuing medical education in Ukraine is in danger. All these
The holy month of worship of Allah, Ramzan will begin with the sighting of the moon. There is a p
We may soon be able to talk to animals. Scientists around the world are trying to talk to bees, e
The atmosphere of the Bigg Boss Season 19 house changes every week after Weekend Ka Vaar. This we
